Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice.

EBV HCMV antibodies dendritic cells herpesvirus humanized mice immortalization virus-like particles

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
21 Dec 2023
Historique:
received: 27 10 2023
revised: 08 12 2023
accepted: 11 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

Antiviral neutralizing antibodies (nAbs) are commonly derived from B cells developed in immunized or infected animals and humans. Fully human antibodies are preferred for clinical use as they are potentially less immunogenic. However, the function of B cells varies depending on their homing pattern and an additional hurdle for antibody discovery in humans is the source of human tissues with an immunological microenvironment. Here, we show an efficient method to pharm human antibodies using immortalized B cells recovered from Nod.Rag.Gamma (NRG) mice reconstituting the human immune system (HIS). Humanized HIS mice were immunized either with autologous engineered dendritic cells expressing the human cytomegalovirus gB envelope protein (HCMV-gB) or with Epstein-Barr virus-like particles (EB-VLP). Human B cells recovered from spleen of HIS mice were efficiently immortalized with EBV in vitro. We show that these immortalized B cells secreted human IgGs with neutralization capacities against prototypic HCMV-gB and EBV-gp350. Taken together, we show that HIS mice can be successfully used for the generation and pharming fully human IgGs. This technology can be further explored to generate antibodies against emerging infections for diagnostic or therapeutic purposes.

Identifiants

pubmed: 38201224
pii: cells13010020
doi: 10.3390/cells13010020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Center for Molecular Medicine Cologne
ID : Project B10

Auteurs

Sebastian J Theobald (SJ)

Department I of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931 Cologne, Germany.
Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany.

Elena Fiestas (E)

Research Unit Gene Vectors, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 81377 Munich, Germany.
Institute of Structural Biology, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany.

Andreas Schneider (A)

Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany.

Benjamin Ostermann (B)

Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany.

Simon Danisch (S)

Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany.

Constantin von Kaisenberg (C)

Department of Obstetrics, Gynecology and Reproductive Medicine, Hannover Medical School, 30625 Hannover, Germany.

Jan Rybniker (J)

Department I of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931 Cologne, Germany.

Wolfgang Hammerschmidt (W)

Research Unit Gene Vectors, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 81377 Munich, Germany.

Reinhard Zeidler (R)

German Center for Infection Research (DZIF), Partner Site Munich, 81377 Munich, Germany.
Institute of Structural Biology, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany.
Department of Otorhinolaryngology, Munich University Hospital, 81377 Munich, Germany.

Renata Stripecke (R)

Department I of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931 Cologne, Germany.
Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany.
Institute of Translational Immuno-Oncology, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.
Cancer Research Center Cologne Essen, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.

Classifications MeSH